Add to ORKGPsoriasis and psoriatic arthritis (PsA) are common conditions that have a significant impact on affect-ed patients. The availability of novel and expensive therapeutic agents for both psoriasis and PsA, suc
Psoriatic arthritis is a heterogeneous condition with substantial challenges in optimising outcome m...
The International Dermatology Outcome Measures (IDEOM) established a set of core domains to be measu...
Psoriatic arthritis (PsA) is rarely assessed in psoriasis randomized controlled trials (RCT); thus, ...
Several tools have been introduced in clinical trials to quantify the severity and the response to a...
Psoriatic arthritis (PsA), an inflammatory arthritis associated with psoriasis usually seronegative ...
Psoriatic arthritis (PsA) is an inflammatory arthritis with multiple manifestations: peripheral/axia...
Psoriatic arthritis (PsA) is an inflammatory arthritis with multiple manifestations: peripheral/ axi...
In order to measure disease activity, progression, and change with therapy in psoriatic arthritis (P...
Psoriatic arthritis (PsA) has been defined as a unique inflammatory arthritis associated with psoria...
Psoriasis (PSO) and psoriatic arthritis (PsA) are two related chronic inflammatory diseases. A propo...
Psoriasis is a common immune-mediated inflammatory condition that primarily affects skin and nails. ...
Psoriatic arthritis (PsA) is characteristically associated with a large spectrum of disorders, some ...
Psoriasis is a common, immune-mediated chronic inflammatory disease with a primary involvement of sk...
Psoriatic arthritis (PsA) increases the disease burden associated with psoriasis by further diminish...
Psoriasis, a chronic systemic inflammatory disease, has a substantial impact on patients’ quality of...
Psoriatic arthritis is a heterogeneous condition with substantial challenges in optimising outcome m...
The International Dermatology Outcome Measures (IDEOM) established a set of core domains to be measu...
Psoriatic arthritis (PsA) is rarely assessed in psoriasis randomized controlled trials (RCT); thus, ...
Several tools have been introduced in clinical trials to quantify the severity and the response to a...
Psoriatic arthritis (PsA), an inflammatory arthritis associated with psoriasis usually seronegative ...
Psoriatic arthritis (PsA) is an inflammatory arthritis with multiple manifestations: peripheral/axia...
Psoriatic arthritis (PsA) is an inflammatory arthritis with multiple manifestations: peripheral/ axi...
In order to measure disease activity, progression, and change with therapy in psoriatic arthritis (P...
Psoriatic arthritis (PsA) has been defined as a unique inflammatory arthritis associated with psoria...
Psoriasis (PSO) and psoriatic arthritis (PsA) are two related chronic inflammatory diseases. A propo...
Psoriasis is a common immune-mediated inflammatory condition that primarily affects skin and nails. ...
Psoriatic arthritis (PsA) is characteristically associated with a large spectrum of disorders, some ...
Psoriasis is a common, immune-mediated chronic inflammatory disease with a primary involvement of sk...
Psoriatic arthritis (PsA) increases the disease burden associated with psoriasis by further diminish...
Psoriasis, a chronic systemic inflammatory disease, has a substantial impact on patients’ quality of...
Psoriatic arthritis is a heterogeneous condition with substantial challenges in optimising outcome m...
The International Dermatology Outcome Measures (IDEOM) established a set of core domains to be measu...
Psoriatic arthritis (PsA) is rarely assessed in psoriasis randomized controlled trials (RCT); thus, ...